Search research articles
Contact Us
Filters
Showing results (71-80 of 116) with videos related to
Page
of 12
Sort By:
Annales D'Endocrinologie
|
April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer
Hélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE
Ségolène Hescot, Véronique Debien, Julien Hadoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 11, 2024
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network
Laure Al Mansour, Louis De Mestier, Magalie Haissaguerre, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Endocrine-Related Cancer
|
August 30, 2022
Prognostic of recurrence and survival in poorly differentiated thyroid cancer
Segolene Hescot, Abir Al Ghuzlan, Theophraste Henry, et al.
Journal of Neuroendocrinology
|
August 21, 2023
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
Lucie Duponchelle, Eric Baudin, Fabien Subtil, et al.
Endocrine-Related Cancer
|
July 13, 2026
Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility
Théodore Vuong, Lambros Tselikas, Julien Hadoux, et al.
Endocrine
|
January 7, 2018
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma
Guillaume Gravel, Sophie Leboulleux, Lambros Tselikas, et al.
JCO Precision Oncology
|
December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2021
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy
Deborah Cosentini, Salvatore Grisanti, Julien Hadoux, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 116) with videos related to
Sort By:
Page
of 12
Annales D'Endocrinologie
|
April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer
Hélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE
Ségolène Hescot, Véronique Debien, Julien Hadoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 11, 2024
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network
Laure Al Mansour, Louis De Mestier, Magalie Haissaguerre, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Endocrine-Related Cancer
|
August 30, 2022
Prognostic of recurrence and survival in poorly differentiated thyroid cancer
Segolene Hescot, Abir Al Ghuzlan, Theophraste Henry, et al.
Journal of Neuroendocrinology
|
August 21, 2023
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
Lucie Duponchelle, Eric Baudin, Fabien Subtil, et al.
Endocrine-Related Cancer
|
July 13, 2026
Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility
Théodore Vuong, Lambros Tselikas, Julien Hadoux, et al.
Endocrine
|
January 7, 2018
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma
Guillaume Gravel, Sophie Leboulleux, Lambros Tselikas, et al.
JCO Precision Oncology
|
December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2021
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy
Deborah Cosentini, Salvatore Grisanti, Julien Hadoux, et al.
Page
of 12